New Issue: HSBC prices $1 million 9% yield notes on Amgen, Biogen, Thermo Fisher shares

By Wendy Van Sickle

Columbus, Ohio, Dec. 23 – HSBC USA Inc. priced $1 million of 9% yield notes due Dec. 27, 2017 linked to the common stocks of Amgen Inc., Biogen Inc. and Thermo Fisher Scientific Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable quarterly.

The payout at maturity will be par unless the shares of any of the stocks finish below their trigger level, 65% of their initial levels, in which case investors will be fully exposed to the decline of the shares of the worst-performing stock from their initial level.

HSBC Securities (USA) Inc. is the agent.

Issuer:	HSBC USA Inc.
Issue:	Yield notes
Underlying stocks:	Amgen Inc., Biogen Inc. and Thermo Fisher Scientific Inc.
Amount:	$1 million
Maturity:	Dec. 27, 2017
Coupon:	9%, payable quarterly
Price:	Par
Payout at maturity:	Par unless any stock finishes below its 65% trigger level, in which case a number of shares of the worst performing stock equal to the principal divided by the initial share price or the cash equivalent
Initial share prices:	$146.17 for Amgen, $283.11 for Biogen and $140.77 for Thermo Fisher
Trigger share prices:	$95.0105 for Amgen, $184.0215 for Biogen and $91.5005 for Thermo Fisher, 65% of initial levels
Pricing date:	Dec. 21
Settlement date:	Dec. 27
Agent:	HSBC Securities (USA) Inc.
Fees:	1%
Cusip:	40433UF76

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.